Cardiovascular effects of intravenous colforsin in normal and acute respiratory acidosis canine models: a dose–response study
Preprint
- 22 February 2019
- preprint
- Published by Cold Spring Harbor Laboratory in bioRxiv
- p. 558221
Abstract
In acidosis, catecholamines are attenuated and higher doses are often required to improve cardiovascular function. Colforsin activates adenylate cyclase in cardiomyocytes without mediating the beta adrenoceptor. In this study, six beagles were administered either colforsin or dobutamine four times during eucapnia (partial pressure of arterial carbon dioxide 35-40 mm Hg; normal) and hypercapnia (ibid 90-110 mm Hg; acidosis) conditions. The latter was induced by carbon dioxide inhalation. Anesthesia was induced with propofol and maintained with isoflurane. Cardiovascular function was measured by thermodilution and a Swan-Ganz catheter. Cardiac output, heart rate, and systemic vascular resistance were determined at baseline and 60 min after 0.3 μg/kg/min (low), 0.6 μg/kg/min (middle), and 1.2 μg/kg/min (high) colforsin administration. The median pH was 7.38 [range 7.34–7.42] and 7.04 [range 7.01–7.08] at baseline in the Normal and Acidosis conditions, respectively. Endogenous adrenaline and noradrenaline levels at baseline were significantly (P< 0.05) higher in the Acidosis than in the Normal condition. Colforsin induced cardiovascular effects similar to those caused by dobutamine. Colforsin increased cardiac output in the Normal condition (baseline: 198.8 mL/kg/min [range 119.6–240.9], low: 210.8 mL/kg/min [range 171.9–362.6], middle: 313.8 mL/kg/min [range 231.2–473.2], high: 441.4 mL/kg/min [range 373.9–509.3];P< 0.001) and the Acidosis condition (baseline: 285.0 mL/kg/min [range 195.9–355.0], low: 297.4 mL/kg/min [213.3–340.6], middle: 336.3 mL/kg/min [291.3–414.5], high: 366.7 mL/kg/min [339.7–455.7] ml/kg/min;P< 0.001). Colforsin significantly increased heart rate (P< 0.05 in both conditions) and decreased systemic vascular resistance (P< 0.05 in both conditions) compared to values at baseline. Systemic vascular resistance was lower in the Acidosis than in the Normal condition (P< 0.001). Dobutamine increased pulmonary artery pressure, whereas colforsin did not. Colforsin offsets the effects of endogenous catecholamines and may not increase cardiac output during hypercapnia.Keywords
All Related Versions
- Published version: PLOS ONE, 14 (7), e0213414.
This publication has 37 references indexed in Scilit:
- Mild metabolic acidosis impairs the β-adrenergic response in isolated human failing myocardiumCritical Care, 2012
- Doppler echocardiography–derived evidence of pulmonary arterial hypertension in dogs with degenerative mitral valve disease: 86 cases (2001–2005)Journal of the American Veterinary Medical Association, 2006
- Impact of dopamine or dobutamine infusions on cardiovascular variables after rapid blood loss and volume replacement during isoflurane-induced anesthesia in dogsAmerican Journal of Veterinary Research, 2006
- Pulmonary vascular effects of dobutamine in experimental pulmonary hypertensionCritical Care Medicine, 2003
- Ventilation with Lower Tidal Volumes as Compared with Traditional Tidal Volumes for Acute Lung Injury and the Acute Respiratory Distress SyndromeNew England Journal of Medicine, 2000
- Comparison of the Renal and Pulmonary Hemodynamic Effects of Fenoldopam, Dobutamine, Dopamine and Norepinephrine in the Anesthetized DogPharmacology, 1988
- Review: The Pharmacology of DobutamineThe American Journal of the Medical Sciences, 1987
- Catecholamine-Induced Hyperglycemia in Dogs: Independence from Alterations in Pancreatic Hormone ReleaseHormone and Metabolic Research, 1980
- Comparative systemic and regional hemodynamic effects of dopamine and dobutamineAmerican Heart Journal, 1975
- The Effects of Changes in Pa CO 2 Cerebral Blood Volume, Blood Flow, and Vascular Mean Transit TimeStroke, 1974